Hunting Buffalo
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“Rationalization is a defense mechanism in which people justify difficult or unacceptable feelings with seemingly logical reasons and explanations.” -Psychology Today
Ya know, I don’t believe anything you say but I sure like the way you talk my man.
🤜🤛
Thanks dude…you just gave us the entire last 4 years history of Revive in just ten words. Brilliant!
The annual meeting must be coming up. Here comes the BS nothingburgers. At least MF is consistent.
We’re broke. Man up and get a grip.
Irrelevant. Nice try Loser.
Where’s your proof the bucillamine patent is worth anything? Come on my man, prove to us it’s not worthless. I’ll wait. The company is upside-down financially. It can’t even pay its debts. We’re broke dude. Don’t you think if there was any interest in the patent MF would have sold it by now to fund the company? Maybe not, he can always r/s and screw the shareholders again.
I on the other hand have given you straight facts from the MD&A filings. That’s the difference between you and I. I deal in reality.
I understand your frustration and you can take it out on me anytime you want. Go ahead and bring it on.
I played the volatility and did not go long. I made a lot of money because I saw the truth about this CEO a long time ago.
R/S or bankruptcy is all that’s left for this POS. Come on Egomike and rickstereo, pull your heads out and pick which one it will be.
From page 16 of MD&A released 10/27/23. Straight from the horse's mouth. What's it going to take for you guys to figure out you've been taken to the cleaners?
"As of June 30, 2023, Revive had $2,087,362 in cash and cash equivalents.
Accounts payable and accrued liabilities were $3,301,134 as of June 30, 2023. The Company’s cash and cash equivalents balance as of June 30, 2023, is not sufficient to pay these liabilities."
No…I don’t think you get it.
Well it’s quite likely he has been playing golf, eating fine food, and traveling the world with your money.
How many times are you going to fall for this bro? MF knows exactly what he's doing and it's working...again. Knock yourself out.
Mar 24, 2021: "The Company is on track to meet its planned enrollment goal for the Study in Q2-2021."
July 15, 2021: "Aim to complete enrollment in Q3-2021 and FDA EUA submission in late-Q3/Q4-2021."
Oct 26, 2021: "Expect to complete enrollment in Q4-2021."
Dec 29, 2021: "Expected to complete enrollment in Q1-2022."
Jan 18, 2022: "On-track to complete enrollment in Q1-2022 and FDA submission thereafter."
Mar 29, 2022: "The Company now expects to complete full enrollment in Q2-2022."
Correct me if I’m wrong but I think the earnings report will be out later this month. Perhaps we will get a glimpse of their cash position, but I see no other way out except an r/s followed by share dilution. The problem is you need buyers in that case. Who in their right mind is going to buy this stock through an offering now? If I recall they had trouble finding buyers in the last offering and the company is in much worse shape now.
Unfortunately it appears like the same, old routine all over again. We’ll see who learned their lesson and who didn’t. You’re right it’s years away from anything and this company has no money. What a combo.
A little defensive ‘eh stereo?
Good point. My problem is when I think of pumpers I think of Hotmeat. LOL. He was beyond bully. In fact I'm sure there's a word for him. I really shouldn't give the impression that all pumpers are bullies.
The pumpers have bullied people on this board for 3 years now. They're time is up and some can't handle it. They were totally wrong about this company and cannot face the music. They're weak and it shows.
Show us the trial that proves it is better than placebo.
Yeah that’s his MO. Let’s see how long he can drag out bucillamine 2.0. The shareholders are giving him $30,000 bucks a month while he plays golf. Stringing investors along fits his lifestyle just fine. Why change now?
University of Waterloo? How appropriate.
Yup…when the cash cow dries up, r/s and dilute. Penny Stock CEO 101. It’s textbook. Or he just continues to ride it out till bankruptcy and pockets his 30K every month. That has worked well for him so far, why should he stop?
No money, no plan, and a 0.018 USD stock price. Hmmm….
There is no need for anyone to spend a dime bashing this stock. Michael Frank has done all the work for free. He has done more than all the bashers combined to drive this stock right into the ground.
You win the grand prize W chocolate! Michael Frank and/or Revive has never completed a phase 3 trial on anything.
“The DSMB recommended that the Study be halted early due to statistical significance of the primary endpoint likely not going to be met should the Study continue towards completion.” -5/12/23 PR
Hey E-Mike, how many experienced investors waste their time on a 2 cent stock that’s running a scam?
I’m a realist. And you?
Okay let's say you're right. So if EcoMike is not a paid pumper, how would you describe his behavior?
Bizarre? You betcha it's bizarre. Goes to show that the bucillamine scam 2.0 is out of the starting blocks. How will you handle it this time?
I’ve been watching this stock for 3 years now. I’ve also seen all 180 Seinfeld episodes. Today Seinfeld is in second place. It’s like I can’t wait to see what MF is going to try next. It’s much better than watching Kramer.
Hark...ye haveth lost thy mind.
I believe there have been no cases reported since 2004.
Yeah I agree but once again the wording of the PR is strange. It said something like working with interested partners for potential approvals. I take that to mean they have nobody from BP knocking on the door, but who knows with the history of MF's vague PRs.
Here’s a post from another message board that lays it out pretty clearly.
“It’s apparent with the recent developments of the bucillamine trial, it is proven that bucillamine is a powerful drug for luring people into the idea that it might be effective against anything to do with breathing. Clinical trials have proven that if you say “it looks as if bucillamine ”or “there might be evidence that bucillamine…” it is a powerful tool for market manipulation. The ability of Bucillamine (alias name of a poster) to put out countless Press Releases, indicates that bucillamine is a powerful tool in the epidemic of ‘pump and dump’ stocks. Bucillamine has proven to be a powerful IP for its CEO and board members to create unlimited hopium for investors. And when 2.0 is added to bucillamine it appears bucillamine can be 2.0 times as effective for bringing in new investors and will extend the life of bucillamine for another year. Who would have thought? Oh… yeah… MF.”
It’s pretty hard to be outraged when you enable and promote the scam.
It’s pretty hard to be outraged when you enable and promote the scam.
Yeah and DSA took a lot of crap at times. With these small, clinical stage biotechs management of the trial is just as important as the drug itself, maybe even more so. I can only speak for myself but it was very apparent early on the behavior of MF was that of a rookie amatuer. It was the 800 pound gorilla in the room. Some wanted to talk about it and some wanted to defend him. It would be interesting if we broke those two groups down to see which got burned the worst.
"There can be no assurance that the Company will proceed with the clinical development and regulatory approvals of Bucillamine for COVID-19 in the U.S. and internationally."
This is a noticeable change from previous PRs. We have not seen this kind of wording or tone from MF in the past. Judge for yourselves.